US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist
  • 2.500
  • +0.020+0.81%
Trading Jul 8 12:30 ET
227.60MMarket Cap-6097P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
8.25%12.05M
6.09%50.58M
23.63%13.21M
13.43%13M
-0.18%13.24M
-9.26%11.13M
-6.20%47.68M
-3.57%10.68M
-13.73%11.46M
-13.55%13.27M
Operating revenue
8.25%12.05M
6.09%50.58M
23.63%13.21M
13.43%13M
-0.18%13.24M
-9.26%11.13M
-6.20%47.68M
-3.57%10.68M
-13.73%11.46M
-13.55%13.27M
Cost of revenue
-7.35%4.39M
7.45%20.83M
-11.80%4.68M
3.74%4.8M
26.23%6.62M
12.41%4.74M
29.33%19.39M
57.61%5.31M
5.11%4.63M
17.38%5.24M
Gross profit
19.81%7.66M
5.15%29.75M
58.58%8.53M
19.98%8.2M
-17.44%6.62M
-20.59%6.4M
-21.06%28.29M
-30.28%5.38M
-23.06%6.84M
-26.25%8.02M
Operating expense
51.07%16.62M
-36.25%44.85M
-22.70%12.44M
-32.57%10.58M
-47.88%10.83M
-38.17%11M
-0.23%70.36M
-16.98%16.09M
-6.91%15.69M
19.48%20.79M
Selling and administrative expenses
43.38%10.69M
-39.96%31.75M
-19.15%9.55M
-40.73%7.39M
-52.78%7.36M
-42.75%7.46M
-1.11%52.88M
-21.15%11.81M
2.72%12.46M
18.68%15.59M
Research and development costs
67.24%5.93M
-25.04%13.1M
-32.49%2.89M
-1.11%3.2M
-33.19%3.47M
-25.69%3.55M
2.55%17.48M
-2.77%4.28M
-31.61%3.23M
21.96%5.2M
Operating profit
-94.51%-8.96M
64.10%-15.1M
63.49%-3.91M
73.15%-2.38M
67.02%-4.21M
52.71%-4.61M
-21.30%-42.07M
8.19%-10.71M
-11.11%-8.85M
-95.83%-12.76M
Net non-operating interest income expense
-129.72%-3.87M
171.77%8.86M
-87.31%-3.07M
105.48%202K
63.31%-1.3M
474.10%13.03M
43.99%-12.34M
52.55%-1.64M
44.09%-3.68M
39.49%-3.54M
Non-operating interest income
-97.73%329K
16,385.86%16.32M
153.85%165K
30,180.00%1.51M
303.13%129K
--14.51M
-76.60%99K
-51.85%65K
--5K
-91.42%32K
Non-operating interest expense
182.45%4.2M
-40.03%7.46M
89.85%3.24M
-64.43%1.31M
-60.02%1.43M
-57.29%1.49M
-44.60%12.44M
-52.52%1.7M
-44.01%3.69M
-42.60%3.57M
Other net income (expense)
-1.38M
-1.03M
-353K
Special income (charges)
--0
---1.38M
---1.03M
--0
--0
---353K
--0
--0
--0
--0
-Less:Other special charges
----
--1.38M
--1.03M
----
----
--353K
----
----
----
----
Income before tax
-259.00%-12.83M
85.99%-7.63M
35.15%-8.01M
82.65%-2.18M
66.21%-5.51M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.3M
Income tax
0
245K
101K
-140K
284K
0
0
0
0
0
Net income
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.3M
Net income continuous Operations
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.3M
Minority interest income
Net income attributable to the parent company
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.3M
Basic earnings per share
-213.33%-0.17
88.39%-0.13
41.71%-0.1341
86.96%-0.03
72.22%-0.1
146.88%0.15
39.46%-1.12
68.06%-0.23
37.84%-0.23
-9.09%-0.36
Diluted earnings per share
-254.55%-0.17
88.39%-0.13
41.71%-0.1341
86.96%-0.03
72.22%-0.1
134.38%0.11
39.46%-1.12
68.06%-0.23
37.84%-0.23
-9.09%-0.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 8.25%12.05M6.09%50.58M23.63%13.21M13.43%13M-0.18%13.24M-9.26%11.13M-6.20%47.68M-3.57%10.68M-13.73%11.46M-13.55%13.27M
Operating revenue 8.25%12.05M6.09%50.58M23.63%13.21M13.43%13M-0.18%13.24M-9.26%11.13M-6.20%47.68M-3.57%10.68M-13.73%11.46M-13.55%13.27M
Cost of revenue -7.35%4.39M7.45%20.83M-11.80%4.68M3.74%4.8M26.23%6.62M12.41%4.74M29.33%19.39M57.61%5.31M5.11%4.63M17.38%5.24M
Gross profit 19.81%7.66M5.15%29.75M58.58%8.53M19.98%8.2M-17.44%6.62M-20.59%6.4M-21.06%28.29M-30.28%5.38M-23.06%6.84M-26.25%8.02M
Operating expense 51.07%16.62M-36.25%44.85M-22.70%12.44M-32.57%10.58M-47.88%10.83M-38.17%11M-0.23%70.36M-16.98%16.09M-6.91%15.69M19.48%20.79M
Selling and administrative expenses 43.38%10.69M-39.96%31.75M-19.15%9.55M-40.73%7.39M-52.78%7.36M-42.75%7.46M-1.11%52.88M-21.15%11.81M2.72%12.46M18.68%15.59M
Research and development costs 67.24%5.93M-25.04%13.1M-32.49%2.89M-1.11%3.2M-33.19%3.47M-25.69%3.55M2.55%17.48M-2.77%4.28M-31.61%3.23M21.96%5.2M
Operating profit -94.51%-8.96M64.10%-15.1M63.49%-3.91M73.15%-2.38M67.02%-4.21M52.71%-4.61M-21.30%-42.07M8.19%-10.71M-11.11%-8.85M-95.83%-12.76M
Net non-operating interest income expense -129.72%-3.87M171.77%8.86M-87.31%-3.07M105.48%202K63.31%-1.3M474.10%13.03M43.99%-12.34M52.55%-1.64M44.09%-3.68M39.49%-3.54M
Non-operating interest income -97.73%329K16,385.86%16.32M153.85%165K30,180.00%1.51M303.13%129K--14.51M-76.60%99K-51.85%65K--5K-91.42%32K
Non-operating interest expense 182.45%4.2M-40.03%7.46M89.85%3.24M-64.43%1.31M-60.02%1.43M-57.29%1.49M-44.60%12.44M-52.52%1.7M-44.01%3.69M-42.60%3.57M
Other net income (expense) -1.38M-1.03M-353K
Special income (charges) --0---1.38M---1.03M--0--0---353K--0--0--0--0
-Less:Other special charges ------1.38M--1.03M----------353K----------------
Income before tax -259.00%-12.83M85.99%-7.63M35.15%-8.01M82.65%-2.18M66.21%-5.51M161.03%8.07M22.87%-54.41M57.33%-12.35M13.87%-12.54M-31.82%-16.3M
Income tax 0245K101K-140K284K00000
Net income -259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M13.87%-12.54M-31.82%-16.3M
Net income continuous Operations -259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M13.87%-12.54M-31.82%-16.3M
Minority interest income
Net income attributable to the parent company -259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M13.87%-12.54M-31.82%-16.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M13.87%-12.54M-31.82%-16.3M
Basic earnings per share -213.33%-0.1788.39%-0.1341.71%-0.134186.96%-0.0372.22%-0.1146.88%0.1539.46%-1.1268.06%-0.2337.84%-0.23-9.09%-0.36
Diluted earnings per share -254.55%-0.1788.39%-0.1341.71%-0.134186.96%-0.0372.22%-0.1134.38%0.1139.46%-1.1268.06%-0.2337.84%-0.23-9.09%-0.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg